Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD)-Reference-Cited by-同舟云学术

Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD)

Published:2020-06-01 Issue:6 Volume:55 Page:706-711
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Gerhardt Florian¹,Petroff David²,Blank Valentin¹³,Böhlig Albrecht¹,van Bömmel Florian¹,Wittekind Christian⁴,Berg Thomas¹,Karlas Thomas¹,Wiegand Johannes¹

Affiliation:

1. Clinic and Polyclinic of Oncology, Gastroenterology, Hepatology, Pneumology and Infectious Diseases, University Hospital Leipzig, Leipzig, Germany;

2. Clinical Trial Center Leipzig, University of Leipzig, Leipzig, Germany;

3. Integrated Research and Treatment Center Adiposity Diseases, University of Leipzig, Leipzig, Germany;

4. Institute of Pathology, University Hospital Leipzig, Leipzig, Germany

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2020.1766554

Reference30 articles.

1. Non-alcoholic fatty liver disease – A global public health perspective

2. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation